Erlotinib Tablet, Film Coated
Product Images NDC 59651-532

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Erlotinib (NDC 59651-532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Erlotinib-fig1 (Erlotinib Fig1)

FDA Label Image

Package Label-principal Display Panel (150 mg (30 Tablets Carton))

This medication package contains erlotinib tablets, each containing 150mg of the active ingredient. Dosage, administration info and storage instructions are found in the package insert. The tablets are not child-resistant. The medication is distributed by Aurobindo Pharma USA from its New Jersey location, but is made in India.*

FDA Label Image

Erlotinib-fig2 (Erlotinib Fig2)

This is a chart showing the survival probability and overall survival of patients who were treated with placebo or Erlotinib over a period of time. The chart also provides the number of patients at risk in each category.*

FDA Label Image

Erlotinib-fig3 (Erlotinib Fig3)

FDA Label Image

Erlotinib-fig4 (Erlotinib Fig4)

FDA Label Image

Package Label-principal Display Panel (25 mg (30 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (25 mg (30 Tablets Carton))

This is a unit-dose package of Erlotinib tablets containing 25mg of erlotinib free base. The package contains 10 (1x10) unit-dose tablets intended for prescription use only. The tablets should be stored at 20-25°C and not child-resistant. The distributor of the package is Aurobindo Pharma USA, Inc. The package also contains Dosage and Administration instructions which refers to an enclosed package insert for further information. The text "Over Printing Zone" appears at the top of the package.*

FDA Label Image

Package Label.principal Display Panel- 100 mg (30 Tablets Bottle) (Erlotinib Fig7)

NDC 59651-531-03 is a prescription drug called Erlotinib Tablets. Each film-coated tablet contains 100 mg of erltinib fres base. The enclosed package insert provides complete prescribing information. It is distributed by Aurobindo Pharma USA, Inc. and made in India. The recommended storage temperature is 20 to 25 degrees Celsius.*

FDA Label Image

Package Label-principal Display Panel (100 mg (30 Tablets Carton))

FDA Label Image

Package Label.principal Display Panel- 150 mg (30 Tablets Bottle) (Erlotinib Fig9)

Erlotinib Tablets are distributed by Aurobindo Pharma USA, Inc. Each coated tablet contains 150mg of erlotinib free base. The package insert for codes TSDRUGS 2472015 should be consulted. The tablets should be stored between 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The medication is only available with a prescription. The provided text does not include non-English characters.*

FDA Label Image

Chemical Structure (Erlotinib Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.